Treating CAP caused by penicillin-resistant S pneumoniae

Journal of Respiratory Diseases

Volumn 20, Issue 12, 1999, Pages 833-842

  File, Thomas M ^a,b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; BRONCHODILATING AGENT; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BRONCHITIS; DISEASE TRANSMISSION; DRUG INDICATION; DRUG USE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; VACCINATION;

EID: 0344286549     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Doern GV. Streptococcus pneumoniae and penicillin: a relationship under stress. Mediguide Infect Dis. 1995;15:1-4.
2. Thornsberry C, Hickey ML, Diakin DR, et al. Sequential surveillance of antimicrobial resistance in the United States. Paper presented at: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy: September 24-28, 1998; San Diego. Abstract E-22.
3. Jacobs MR, Bajaksousian S, Lin G, Appelbaum PC. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to oral agents: results of a 1997 epidemiological survey. In: Program and abstracts of the 98th General Meeting of the American Society of Microbiology; May 17-21, 1998; Atlanta. Abstract A-31.
4. Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. 1998;27:764-770.
5. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis, 1997; 24(suppl):S85-S88.
6. Kaplan SL, Mason EO Jr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998;11:628-644.
7. Klugman KP, Feldman C. The clinical relevance of antibiotic resistance in the management of pneumococcal pneumonia. Infect Dis Clin Prac. 1998;7:180-184.
8. Ho P-L, Que T-L, Tsang DN-C, et al. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother. 1999;43:1310-1313.
9. Chen DK, McGeer A, De Azavedo JC, et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med. 1999;341:233-239.
10. Bryan CS, Tahwani R, Stinson MS. Penicillin dosing for pneumococcal pneumonia. Chest. 1997;112:1657-1664.
11. Siegel RE. The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumonias and community-acquired pneumonia. Chest. 1999;116:535-538.
12. Pallares R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480.
13. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 1995;14:885-890.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; ninth informational supplement: M100-S9, Wayne, Pa. 1999;19:90-91.
15. Garcia-Leoni ME, Cerenado E, Rodeño P, et al. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis. 1992;14:427-435.
16. Baril L, Astagneau P, Nguyen J, et al. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected patients: a clinical radiological, microbiological, and epidemiological study. Clin Infect Dis. 1998;26:964-971.
17. Tan TQ, Mason EO Jr, Kaplan SL. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992;90:928-933.
18. Sanches C, Armengol R, Lite J, et al. Penicillin-resistant pneumococci and community-acquired pneumonia. Lancet. 1992;339:988.
19. Feikin D, Cetron FD, Schuchat A. Multistate population based assessment of mortality from drug-resistant Streptococcus pneumoniae. Paper presented at: 35th Annual Meeting of the Infectious Diseases Society of America; September 13-16, 1997; San Francisco. Abstract 48.
20. Turett GS, Blum S, Fazal BA, et al. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus saroprevalence. Clin Infect Dis. 1999; 29:321-327.
21. Dowell SFS, Smith T, Leversedge K, et al. Failure of treatment of pneumoniae associated with highly resistant pneumococci in a child. Clin Infect Dis. 1999;29:462-463.
22. Buckingham SC, Brown SP, Joaquin VH. Breakthrough bacteremia and meningitis during treatment parenterally with cephalosporins for pneumococcal pneumonia. J Pediatr. 1998;132:174-176.
23. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1-12.
24. Whitney CG, Barrett N, Parley M, et al. Increasing prevalence of drug-resistant Streptococcus pneumoniae: implications for therapy of pneumonia. Paper presented at: 36th Annual Meeting of the Infectious Disease Society of America; November 12-15, 1998; Denver. Abstract 51.
25. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 1998;26:811-838.
26. Jernigan DB, Cetron MS, Breiman RF. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR. 1996;45:1-20.
27. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273:214-217.
28. O'Brien KL, Dowell SF, Schwartz B, et al. Cough illness/bronchitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(suppl):178-181.
29. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antibiotic resistance. JAMA. 1997;278:944-945.
30. Gwaltney JM, Hendley JD, Simon G. Rhinovirus infections in an industrial population II: characteristics of illness and antibody response. JAMA. 1967;202:494-500.
31. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? JAMA. 1997;278:1440-1445.
32. Gwaltney JM. Acute bronchitis. In: Mandell GL, Bennet JE, Dolin R, et al, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995: 606-608.
33. Niroumand M, Grossman RF. Airway infection. Infect Dis Clin North Am. 1998;12: 671-688.
34. Reimer LG, Carroll KC. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis. 1998;26:742-748.
35. MacKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med. 1996;11:557-562.
36. Hueston WJ, Mainous AG. Acute bronchitis. Am Fam Physician. 1998;57:1270-1276.
37. Bent S, Saint S, Vittinghoff E, Grady D. Antibiotics in acute bronchitis: a meta-analysis. Am J Med. 1999;107:62-67.
38. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infection, and bronchitis by ambulatory care physicians. JAMA. 1997; 278:901-904.
39. Oeffinger KC, Snell LM, Foster BM, et al. Treatment of acute bronchitis in adults: a national survey of family physicians. J Fam Pract. 1998;46:469-475.
40. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract. 1996;43:56-62.
41. Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory tract infections. Pediatr Infect Dis J. 1993;12:115-120.
42. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281: 1512-1519.
43. Campbell GD Jr, Silberman R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis. 1998;26:1188-1195.